Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

MAML1 protein, human

Known as: Mastermind-Like 1, hMam-1 protein, human, mastermind protein, human 
Mastermind-like protein 1 (1016 aa, ~108 kDa) is encoded by the human MAML1 gene. This protein is involved in the regulation of notch-dependent gene… Expand
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2019
Review
2019
INTRODUCTION Glioblastoma (GBM) is the most common and deadly form of brain tumor. After standard treatment of resection… Expand
2016
2016
ABSTRACT Like many Alphaherpesvirinae subfamily members, bovine herpesvirus 1 (BoHV-1) expresses an abundant transcript in… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
2013
2013
Background: PTEN loss promotes resistance to γ-secretase inhibitors by increasing AKT signaling in T-cell acute lymphoblastic… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
2011
2011
Human vascular endothelial growth factor (VEGF) and its receptor (VEGFR‐2/kinase domain receptor [KDR]) play a crucial role in… Expand
2007
2007
Mastermind (Mam) is one of the elements of Notch signaling, an ancient system that plays a pivotal role in metazoan development… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
2007
2007
It has been proposed that heterogeneity in natural killer (NK)-cell phenotype and function can be achieved through distinct… Expand
2007
2007
Oligodendrocyte progenitor (OP) cell differentiation is a critical process of developmental myelination, tumor formation, and… Expand
Highly Cited
2007
Highly Cited
2007
Misregulation of the Wnt signaling pathway has been linked to many human cancers including colon carcinoma and melanoma. The… Expand
2007
2007
It has been proposed that heterogeneity in natural killer (NK)–cell phenotype and function can be achieved through distinct… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
2007
2007
BackgroundTo gain a better understanding of the effects of therapeutic agents on the tumor microenvironment in invasive cancers… Expand
  • figure 2
  • figure 3
  • figure 4
  • table 2
  • table 2